Logo image of PRME

PRIME MEDICINE INC (PRME) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:PRME - US74168J1016 - Common Stock

4.065 USD
+0.08 (+1.88%)
Last: 1/16/2026, 11:15:02 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
PRME revenue by date.PRME revenue by date.
2.983M6.318M
111.80%
4.743M
-24.93%
19.742M
316.23%
2.356M
-88.07%
5.841M
147.92%
17.295M
196.10%
102.21M
490.98%
429.67M
320.38%
841.34M
95.81%
EBITDA
YoY % growth
PRME ebitda by date.PRME ebitda by date.
-114.32M
-36.26%
-200.139M
-75.07%
-196.339M
1.90%
-196.966M
-0.32%
-163.331M
17.08%
-176.637M
-8.15%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
PRME ebit by date.PRME ebit by date.
-116.54M
-37.97%
-204.792M
-75.73%
-202.467M
1.14%
-205.239M
-1.37%
-175.421M
14.53%
-188.171M
-7.27%
-211.785M
-12.55%
-213.587M
-0.85%
-206.014M
3.55%
-151.375M
26.52%
123.91M
181.86%
414.88M
234.82%
Operating Margin
PRME operating margin by date.PRME operating margin by date.
N/AN/A-6,787.36%-3,248.48%-3,698.52%-953.15%-8,989.19%-3,656.68%-1,191.17%-148.10%28.84%49.31%
EPS
YoY % growth
PRME eps by date.PRME eps by date.
N/A-2.18
26.93%
-1.65
24.31%
-1.32
19.72%
-0.97
26.88%
-0.89
7.71%
-0.87
3.02%
-0.78
9.65%
-0.72
8.07%
-0.41
42.63%
0.42
202.05%
1.56
269.39%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth
-0.25
18.37%
-0.25
38.67%
-0.24
40.82%
-0.25
22.86%
-0.27
-5.48%
-0.29
-19.33%
-0.31
-28.64%
-0.32
-27.69%
-0.33
-22.29%
-0.35
-20.21%
-0.38
-21.57%
-0.38
-21.68%
Revenue
Q2Q % growth
2.353M
7.79%
510K
-64.92%
7.293M
554.08%
7.293M
495.35%

-100.00%
N/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth
-44.536M
-16.91%
-35.433M
30.10%
-38.302M
23.11%
-39.148M
19.33%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-47.709M
-7.89%
-40.925M
21.89%
-42.261M
20.83%
-43.903M
18.66%
-49.062M
-2.84%
N/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.32
27.27%
-0.26-0.06-24.00%
Q2 2025
Q2Q % growth
-0.41
10.87%
-0.37-0.04-10.55%
Q1 2025
Q2Q % growth
-0.40
9.09%
-0.33-0.07-22.51%
Q4 2024
Q2Q % growth
-0.31
56.94%
-0.400.0922.47%
Q3 2024
Q2Q % growth
-0.44
20.00%
-0.40-0.04-9.16%
Q2 2024
Q2Q % growth
-0.46
2.13%
-0.41-0.05-11.84%
Q1 2024
Q2Q % growth
-0.44 -0.480.048.86%
Q4 2023
Q2Q % growth
-0.72
-28.57%
-0.52-0.20-38.48%
Q3 2023
Q2Q % growth
-0.55 -0.47-0.08-17.22%
Q2 2023
Q2Q % growth
-0.47 -0.43-0.04-8.85%
Q1 2023
Q2Q % growth
-0.44 -0.42-0.02-4.20%
Q4 2022
Q2Q % growth
-0.56 -0.670.1115.86%
PRME Yearly EPS VS EstimatesPRME Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 -2
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
1.225M
486.12%
1.047M178K17.00%
Q2 2025
Q2Q % growth
1.115M 1.53M-415K-27.12%
Q1 2025
Q2Q % growth
1.454M
146.02%
1.07M384K35.89%
Q4 2024
Q2Q % growth
2.183M 293.25K1.89M644.42%
Q3 2024
Q2Q % growth
209K 7.987M-7.778M-97.38%
Q2 2024
Q2Q % growth
1.663M-1.663M-100.00%
Q1 2024
Q2Q % growth
591K 165.75K425.25K256.56%
PRME Yearly Revenue VS EstimatesPRME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -21.07% 0% -8.7%
Revenue11.1% -33.77% 0% -24.24%